Barrow Hanley Mewhinney & Strauss LLC Buys New Shares in Dolby Laboratories $DLB

Barrow Hanley Mewhinney & Strauss LLC bought a new position in shares of Dolby Laboratories (NYSE:DLB – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 687,911 shares of the electronics maker’s stock, valued at approximately $40,429,000. Barrow Hanley Mewhinney & Strauss LLC owned 0.73% of Dolby Laboratories at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. Bank of New York Mellon Corp bought a new position in shares of Dolby Laboratories in the second quarter worth about $253,289,000. Dimensional Fund Advisors LP lifted its holdings in shares of Dolby Laboratories by 6.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,321,407 shares of the electronics maker’s stock worth $79,357,000 after buying an additional 83,835 shares in the last quarter. Advisors Asset Management Inc. purchased a new position in shares of Dolby Laboratories in the third quarter worth $34,670,000. Pacer Advisors Inc. boosted its position in shares of Dolby Laboratories by 8.0% during the first quarter. Pacer Advisors Inc. now owns 516,292 shares of the electronics maker’s stock worth $31,008,000 after acquiring an additional 38,389 shares during the last quarter. Finally, Wellington Management Group LLP boosted its position in shares of Dolby Laboratories by 19.4% during the second quarter. Wellington Management Group LLP now owns 320,156 shares of the electronics maker’s stock worth $16,834,000 after acquiring an additional 52,053 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Price Performance

DLB stock opened at $55.22 on Friday. Dolby Laboratories has a 12 month low of $48.26 and a 12 month high of $69.95. The firm’s 50-day moving average is $60.46 and its 200 day moving average is $59.29. The company has a market capitalization of $5.17 billion, a PE ratio of 20.45 and a beta of 0.79.

Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings results on Tuesday, November 17th. The electronics maker reported $1.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.05. Dolby Laboratories had a return on equity of 11.77% and a net margin of 18.14%. The firm had revenue of $373.54 million during the quarter, compared to analyst estimates of $372.76 million. During the same quarter in the previous year, the business earned $0.99 earnings per share. Dolby Laboratories’s quarterly revenue was up 21.7% on a year-over-year basis. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. Sell-side analysts forecast that Dolby Laboratories will post 3.36 EPS for the current fiscal year.

Dolby Laboratories Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 9th. Stockholders of record on Tuesday, December 1st will be given a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Tuesday, December 1st. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.36. Dolby Laboratories’s dividend payout ratio is currently 53.33%.

Dolby Laboratories announced that its board has authorized a share repurchase program on Thursday, July 30th that authorizes the company to repurchase $350 million in outstanding shares. This buyback authorization authorizes the electronics maker to reacquire up to 7% of its shares through open market purchases. Stock buyback programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on DLB shares. Rosenblatt Securities reduced their target price on Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating on the stock in a report on Monday, November 16th. Robert W. Baird dropped their price target on Dolby Laboratories from $62.00 to $60.00 and set a “neutral” rating for the company in a research note on Thursday. Weiss Ratings raised shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, September 9th. Zacks Research raised Dolby Laboratories from a “strong sell” rating to a “hold” rating in a research note on Friday, November 13th. Finally, Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $76.67.

Get Our Latest Stock Report on Dolby Laboratories

Insiders Place Their Bets

In related news, SVP John Couling sold 7,667 shares of the company’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $58.78, for a total value of $450,666.26. Following the completion of the sale, the senior vice president directly owned 166,803 shares of the company’s stock, valued at $9,804,680.34. This represents a 4.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Ryan Nicholson sold 1,183 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total transaction of $77,226.24. Following the transaction, the chief accounting officer owned 34,453 shares in the company, valued at approximately $2,249,091.84. The trade was a 3.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 16,517 shares of company stock worth $995,963 in the last three months. Corporate insiders own 37.93% of the company’s stock.

About Dolby Laboratories

(Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

Featured Stories

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.